Aduro Biotech, Inc.

Quick facts

Phase 2 pipeline

• CRS-207 · Oncology
  CRS-207 is a live, attenuated Listeria monocytogenes vaccine that stimulates an immune response against mesothelin.
• GVAX Pancreas
• Immunotherapy plus chemotherapy

Phase 1 pipeline

• Immunotherapy with cyclophosphamide plus chemotherapy

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aduro Biotech, Inc. portfolio CI brief
• Aduro Biotech, Inc. pipeline updates RSS